对《莱姆病治疗后持续症状的患病率：一项前瞻性观察队列研究》的关注——作者回复的勘误
Correction to "Concerns about the external validity of the study 'prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study'-authors' reply".
出版信息
Lancet Reg Health Eur. 2022 Jul 22;19:100449. doi: 10.1016/j.lanepe.2022.100449. eCollection 2022 Aug.
Abstract
[This corrects the article DOI: 10.1016/j.lanepe.2022.100344.].
摘要
[本文更正了文章的数字对象标识符：10.1016/j.lanepe.2022.100344。]
相似文献
1
Correction to "Concerns about the external validity of the study 'prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study'-authors' reply".对《莱姆病治疗后持续症状的患病率：一项前瞻性观察队列研究》的关注——作者回复的勘误
Lancet Reg Health Eur. 2022 Jul 22;19:100449. doi: 10.1016/j.lanepe.2022.100449. eCollection 2022 Aug.
2
Concerns about the external validity of the study 'prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study'-authors´ reply.关于“莱姆病治疗后持续症状的患病率：一项前瞻性观察队列研究”的外部有效性的担忧——作者回复
Lancet Reg Health Eur. 2022 Mar 22;15:100344. doi: 10.1016/j.lanepe.2022.100344. eCollection 2022 Apr.
3
Corrections to "Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study" [The Lancet Regional Health - Europe 6 (2021) 100142].对《莱姆病螺旋体病治疗后持续症状的患病率：一项前瞻性观察队列研究》[《柳叶刀区域健康 - 欧洲》6（2021）100142]的更正
Lancet Reg Health Eur. 2023 Mar 15;27:100622. doi: 10.1016/j.lanepe.2023.100622. eCollection 2023 Apr.
4
Concerns about the external validity of the study 'Prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study'.对研究“莱姆病疏螺旋体病治疗后持续症状的患病率：一项前瞻性观察队列研究”的外部有效性的担忧。
Lancet Reg Health Eur. 2022 Mar 22;15:100340. doi: 10.1016/j.lanepe.2022.100340. eCollection 2022 Apr.
5
Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).治疗莱姆病后持续性症状的患病率及其决定因素：一项观察性、前瞻性队列研究（LymeProspect）的研究方案。
BMC Infect Dis. 2019 Apr 15;19(1):324. doi: 10.1186/s12879-019-3949-8.
6
Corrigendum to 'Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study' [The Lancet Regional Health - Europe 35 (2023) 100747].《“奥密克戎时代COVID-19对免疫功能低下人群的影响：基于人群的观察性INFORM研究的见解”的勘误》[《柳叶刀区域健康 - 欧洲》35卷（2023年）100747]
Lancet Reg Health Eur. 2024 Jul 25;44:101008. doi: 10.1016/j.lanepe.2024.101008. eCollection 2024 Sep.
7
The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.HUMTICK研究：关于比利时莱姆病治疗后综合征以及莱姆病螺旋体病的疾病和成本负担的前瞻性队列研究方案。
Arch Public Health. 2017 Aug 7;75:42. doi: 10.1186/s13690-017-0202-z. eCollection 2017.
8
Classification of patients referred under suspicion of tick-borne diseases, Copenhagen, Denmark.丹麦哥本哈根疑似蜱传疾病患者分类。
Ticks Tick Borne Dis. 2021 Jan;12(1):101591. doi: 10.1016/j.ttbdis.2020.101591. Epub 2020 Oct 9.
9
Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis.莱姆病和其他蜱传疾病。法国科学学会指南（二）。生物学诊断、治疗、有记录或疑似莱姆病后持续存在的症状。
Med Mal Infect. 2019 Aug;49(5):335-346. doi: 10.1016/j.medmal.2019.05.001. Epub 2019 May 31.
10
Comparison of Clinical Course and Treatment Outcome for Patients With Early Disseminated or Early Localized Lyme Borreliosis.早期播散型或早期局限型莱姆病患者的临床病程与治疗结果比较
JAMA Dermatol. 2018 Sep 1;154(9):1050-1056. doi: 10.1001/jamadermatol.2018.2306.
Zotero 插件